not FDA-approved as of January 2025 Best Phase 2 result / 24.2% mean body weight loss at 48 weeks (12 mg dose, N=338 trial) Extended estimate / 28.7% mean weight loss projected at 68 weeks in Phase 2 modeling Dosing schedule / Once weekly subcutaneous injection (doses 1 mg through 12 mg tested) Comparator benchmark / Semaglutide 2.4 mg: 14.9% at 68 weeks (STEP-1, N=1,961) Comparator benchmark / Tirzepatide 15 mg: 20.9% at 72 weeks (SURMOUNT-1, N=2,539) Primary side effects / Nausea, vomiting, diarrhea, constipation (dose-dependent) Phase 3 status / Phase 3 program (TRIUMPH trials) enrolling as of 2024 Manufacturer / Eli Lilly and Company What Is Retatrutide
Additional Benefits of Glutathione Shots Because this essential antioxidant helps protect and repair cells, there are a wide range of potential injectable glutathione benefits
Specific Evidence for No IGF-1 Effects: Blood samples collected at baseline and throughout the treatment period measured serum IGF-1 concentrations using validated immunoassays
If oxidative stress or detox support is your priority alongside sleep, NACs effects on sleep quality and rest and combining NAC and taurine for enhanced sleep support are worth researching separately
Formulated with soy- and sunflower-derived lecithins